Levels of C-reactive protein, LDL, IL-1α, and IL-1β as Potential Indicators of Heart Disease
DOI:
https://doi.org/10.47611/jsrhs.v10i3.2197Keywords:
early-detection, C-reactive protein, coronary artery disease, atherosclerosis, low-density lipoproteins, interleukin-1α, interleukin-1β, biomarkersAbstract
C-reactive protein, interleukin-1α, and interleukin-1β are biomarkers that are important in the early detection of heart disease and atherosclerosis. There are many different types of heart diseases, but coronary artery disease is the most common. Heart disease kills hundreds of thousands of people every year because it is usually detected late and its general complications at the later stages. Often, by the time a patient is diagnosed, the heart disease has progressed to its later stages where treatment is not as effective. One of the current diagnostic tests that are conducted is called an electrocardiogram (EKG), and it is very expensive, reducing cost-effectiveness. In this paper, the relevance of C-reactive protein, interleukin 1α, interleukin 1β, and low-density lipoprotein to the indication of heart diseases and the use of those in early detection is discussed. In addition, there is an in-depth review of the correlations between each of the biomarkers and the severity of atherosclerosis within patients.
Downloads
References or Bibliography
Centers for Disease Control and Prevention. (2020, September 8). Heart disease facts. Centers for Disease Control and Prevention. https://www.cdc.gov/heartdisease/facts.htm.
Atherosclerosis. (n.d.). Johns Hopkins Medicine. Retrieved November 4, 2021, from https://www.hopkinsmedicine.org/health/conditions-and-diseases/atherosclerosis.
Blood tests to determine risk of coronary artery disease. Cleveland Clinic. (n.d.). Retrieved November 8, 2021, from https://my.clevelandclinic.org/health/diagnostics/16792-blood-tests-to-determine-risk-of-coronary-artery-disease.
NCI Dictionary of Cancer terms. National Cancer Institute. (n.d.). https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker.
Zakynthinos, E., & Pappa, N. (2009, January 29). Inflammatory biomarkers in coronary artery disease. Journal of Cardiology. https://www.sciencedirect.com/science/article/pii/S0914508709000112.
Mayo Foundation for Medical Education and Research. (2020, June 5). Coronary artery disease. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20350613.
Nehring, S. M. (2021, May 10). C reactive protein. StatPearls [Internet]. Retrieved November 9, 2021, from https://www.ncbi.nlm.nih.gov/books/NBK441843/.
U.S. National Library of Medicine. (n.d.). Pubmed central image viewer. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click+on+image+to+zoom&p=PMC3&id=2788964_nihms159103f1.jpg.
Szekely, Y., & Arbel, Y. (2018, June). A review of interleukin-1 in heart disease: Where do we stand today? Cardiology and therapy. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986669/.
Wæhre, T., Torgun Wæhre From the Research Institute of Internal Medicine (T.W., Yndestad, A., Arne Yndestad From the Research Institute of Internal Medicine (T.W., Smith, C., Camilla Smith From the Research Institute of Internal Medicine (T.W., Haug, T., Terje Haug From the Research Institute of Internal Medicine (T.W., Tunheim, S. H., Siv Haugen Tunheim From the Research Institute of Internal Medicine (T.W., Gullestad, L., Lars Gullestad From the Research Institute of Internal Medicine (T.W., Frøland, S. S., Stig S. Frøland From the Research Institute of Internal Medicine (T.W., Semb, A. G., Anne G. Semb From the Research Institute of Internal Medicine (T.W., Aukrust, P., Pål Aukrust From the Research Institute of Internal Medicine (T.W., Damås, J. K., … Wæhre, C. to T. (2004, March 29). Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-COA reductase inhibitors. Circulation. https://www.ahajournals.org/doi/10.1161/01.CIR.0000125700.33637.B1.
Szekely, Y., & Arbel, Y. (2018, June). A review of interleukin-1 in heart disease: Where do we stand today? Cardiology and therapy. Retrieved November 9, 2021, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986669/.
Structural and functional characterization of cardiac fibroblasts. Oxford Academic. (n.d.) (2005, January 1). https://academic.oup.com/cardiovascres/article/65/1/40/310243.
Woodcock, E. A., & Matkovich, S. J. (2005, May 23). Cardiomyocytes structure, function and associated pathologies. The International Journal of Biochemistry & Cell Biology. Retrieved November 8, 2021, from https://www.sciencedirect.com/science/article/abs/pii/S1357272505001342.
Momeni, H. R. (2011, August 24). Role of calpain in apoptosis. Cell journal. Retrieved November 9, 2021, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584455/.
Bujak, M., & Frangogiannis, N. G. (2009). The role of IL-1 in the pathogenesis of heart disease. Archivum immunologiae et therapiae experimentalis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2788964/.
Mayo Foundation for Medical Education and Research. (2020, June 5). Coronary artery disease. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/diagnosis-treatment/drc-20350619.
Hoffman, M. (n.d.). LDL cholesterol: Definition, risks, and how to lower it. WebMD. Retrieved November 8, 2021, from https://www.webmd.com/heart-disease/ldl-cholesterol-the-bad-cholesterol.
Mayo Foundation for Medical Education and Research. (2021, February 9). Heart disease. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/heart-disease/symptoms-causes/syc-20353118.
WebMD. (n.d.). Coronary artery disease? causes, symptoms, treatment, prevention. WebMD. https://www.webmd.com/heart-disease/coronary-artery-disease.
Paffen, E., & deMaat, M. P. M. (2006, July 1). C-reactive protein in atherosclerosis: A causal factor? OUP Academic. https://academic.oup.com/cardiovascres/article/71/1/30/269442#3249032.
Sproston, N. R., & Ashworth, J. J. (2018, April 13). Role of C-reactive protein at sites of inflammation and infection. Frontiers in immunology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908901/.
Apoptosis. Genome.gov. (n.d.). Retrieved November 8, 2021, from https://www.genome.gov/genetics-glossary/apoptosis.
Mai, W., & Liao, Y. (1AD, January 1). Targeting il-1β in the treatment of Atherosclerosis. Frontiers. https://www.frontiersin.org/articles/10.3389/fimmu.2020.589654/full.
Thrombosis. Johns Hopkins Medicine. (n.d.). https://www.hopkinsmedicine.org/health/conditions-and-diseases/thrombosis.
Tee, K. (n.d.). Heart attack. HealthXchange. https://www.healthxchange.sg/heart-lungs/heart-attack/atherosclerosis-plaque-heart-attack.
Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013, October 22). Targeting interleukin-1 in heart disease. Circulation. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938092/.
Galea J;Armstrong J;Gadsdon P;Holden H;Francis SE;Holt CM; (n.d.). Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arteriosclerosis, thrombosis, and vascular biology. https://pubmed.ncbi.nlm.nih.gov/8696938/.
Shah SR;Abbasi Z;Fatima M;Ochani RK;Shahnawaz W;Asim Khan M;Shah SA; (n.d.). Canakinumab and Cardiovascular Outcomes: Results of the CANTOS trial. Journal of community hospital internal medicine perspectives. https://pubmed.ncbi.nlm.nih.gov/29441161/.
Sproston, N. R., & Ashworth, J. J. (2018, April 13). Role of C-reactive protein at sites of inflammation and infection. Frontiers in immunology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908901/.
Čejková, S., Králová-Lesná, I., & Poledne, R. (2015, September 11). Monocyte adhesion to the endothelium is an initial stage of atherosclerosis development. Cor et Vasa. https://www.sciencedirect.com/science/article/pii/S0010865015000818.
Emerging Risk Factors Collaboration, Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M. B., Thompson, S. G., Collins, R., & Danesh, J. (2010, January 9). C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet (London, England). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162187/.
What Does Minor Elevation of C-Reactive Protein Signify? Define_me. (n.d.). https://www.amjmed.com/article/S0002-9343(05)00563-2/pdf.
Mayo Foundation for Medical Education and Research. (2021, June 25). C-Reactive Protein Test. Mayo Clinic. Retrieved November 8, 2021, from https://www.mayoclinic.org/tests-procedures/c-reactive-protein-test/about/pac-20385228.
Get your cholesterol checked. Get Your Cholesterol Checked - MyHealthfinder. (n.d.). Retrieved November 8, 2021, from https://health.gov/myhealthfinder/topics/doctor-visits/screening-tests/get-your-cholesterol-checked.
Electrocardiogram cost and procedure comparison. NewChoiceHealth.com. (n.d.). https://www.newchoicehealth.com/procedures/electrocardiogram.
Foundation, A. B. I. M. (2018, November 1). Ekgs and exercise stress tests: Choosing wisely. Choosing Wisely | Promoting conversations between providers and patients. https://www.choosingwisely.org/patient-resources/ekgs-and-exercise-stress-tests/
C-reactive protein test to screen for heart disease: Why do we need another test? Harvard Health. (2017, March 21). https://www.health.harvard.edu/heart-health/c-reactive-protein-test-to-screen-for-heart-disease.
Published
How to Cite
Issue
Section
Copyright (c) 2021 Ishan Garg, Heer Nanda; Michele Leibundgut
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
